Dynavax Technologies
DVAX
#4862
Rank
ยฃ1.37 B
Marketcap
ยฃ11.69
Share price
0.00%
Change (1 day)
7.85%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.21 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is ยฃ0.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.20 B0.53%
2023-12-31ยฃ0.20 B-5.44%
2022-12-31ยฃ0.21 B11.85%
2021-12-31ยฃ0.19 B19.31%
2020-12-31ยฃ0.15 B-3.17%
2019-12-31ยฃ0.16 B107.71%
2018-12-31ยฃ79.46 M
2014-12-31ยฃ6.13 M
2012-12-31N/A-100%
2011-12-31ยฃ8.24 M7.98%
2010-12-31ยฃ7.63 M-0.25%
2009-12-31ยฃ7.65 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ48.24 B 22,340.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ41.19 B 19,057.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ4.96 B 2,207.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ18.81 B 8,648.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ37.21 B 17,210.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ21.98 B 10,126.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ18.00 B 8,272.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
ยฃ34.52 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.89 B 5,897.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel